Prostate cancer ‘drug holiday’ to change care for recurring diseaseCHICAGO | Canadian research shows that men with prostate cancer who are treated with intermittent courses of androgen-suppressing therapy live as long as those who receive continuous therapy. Regional riddle emerges from epilepsy drug studyNew treatment is effective in Canada and U.S., but not in rest of North America; epilepsy classification may have been a factor POLL: Mixing conference work and travel appealing to MDs MD may be the longest lived end-stage renal patient Dr. Robin Eady has unique connection to Canada International survey shows risks for living liver donors Need for all centres to routinely report near-misses, expert says Residency hours being reviewed at national level Challenge is in balancing adequate training, fatigue and patient safety, particularly with differing demands in various fields Euthanasia debate rears its head at CMA meeting Canadians honoured at ATC Shorter radiotherapy trumpeted for high-risk prostate cancer TRANSPLANTATION: Surprise OR findings can halt liver donation First Previous 2 3 4 Next Last
